Empagliflozin Reduces Realworld Heart Failure Hospitalization In Type 2 Diabetes | Latest News RSS feed
Empagliflozin Reduces Realworld Heart Failure Hospitalization In Type 2 Diabetes - Latest News
Empagliflozin reduces real-world heart failure hospitalization in type 2 diabetes
Compared with DPP-IV inhibitors, the SGLT2 inhibitor empagliflozin was associated with a 44% relative risk reduction in hospitalization for heart failure in people with type 2 diabetes with and withou... read more
Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization
CHICAGO — Patients with type 2 diabetes (T2D) treated with empagliflozin as part of routine clinical care, experienced a decrease in risk of heart failure hospitalization, according to research presen... read more
EMPA-HEART: Empagliflozin May Reduce LV Mass in Patients With CVD, Diabetes
CHICAGO — Treatment with the sodium glucose cotransporter-2 ... type 2 diabetes, especially if they have a history of heart failure and especially if they have a history of coronary heart disease," di... read more
Looking for another news?
Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors ...
--(BUSINESS WIRE)--Initial effectiveness results from the real-world EMPagliflozin ... in people with type 2 diabetes and established cardiovascular disease. 1,2 “With more than a million hospital adm... read more
Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD
(RTTNews) - New data presented showed that Jardiance reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and ... by 38 percent ... read more
New study shows Jardiance consistently reduced the risk of CV death in type 2 diabetes patients
New data presented at the American Heart ... disease type. Observed adverse events were consistent with the known safety profile of Jardiance. "Jardiance is the only oral type 2 diabetes medicine show... read more
Can diabetes medication improve heart structure?
Led by St Michael's Hospital researchers, the study was presented at the American Heart Association meeting in Chicago. "Empagliflozin is used to reduce glucose ... and how it may prevent heart failur... read more
Study suggests diabetes medication improves heart structure
A study led by St. Michael's Hospital researchers ... cardiac structure in people with Type 2 diabetes who also have heart disease. "Empagliflozin is used to reduce glucose in diabetes patients ... read more
Lilly (LLY) says Initial results from EMPRISE real-world evidence study show Jardiance was associated with reduced risk for HHF
Claim your 2-week ... that empagliflozin is associated with a reduction in hospitalization for heart failure, and the effect is consistent in people with type 2 diabetes with and without history of ca... read more
Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisati...
Empagliflozin was associated with a 44 percent reduction in relative risk of hospitalization ... heart failure, and the effect is consistent in people with type 2 diabetes with and without history of ... read more
DECLARE-TIMI 58: Dapagliflozin Cuts Heart Failure in Diabetes
The large cardiovascular (CV) outcome trials of newer type 2 diabetes ... reduce the risk of heart failure hospitalization in diabetics with, or at increased risk of, heart disease, but the absolute r... read more
Diabetes drug reduces risk of heart failure and may prevent it, study shows
For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations ... reductions in hospitalizations for heart failure (35%); the combined result for heart failure ... read more